Phase I Trial of MRI-Guided Prostate Cancer Lattice Extreme Ablative Dose (LEAD) Boost Radiation Therapy

Abstract
No abstract available
Funding Information
  • National Cancer Institute
  • National Institutes of Health (R21CA153826)

This publication has 46 references indexed in Scilit: